Downregulation of several miRNAs targeting classical proliferative signaling pathways such as EGFR/ErbB1 has been demonstrated in association with ADPKD (Harskamp et al., 2016). The gene discussed is EGFR; the disease is autosomal dominant polycystic kidney disease.